Is progestogen supplementation necessary to prevent abortion?

Area of Science:

• Obstetrics and Gynecology
• Reproductive Endocrinology

Background:

• Threatened abortion (TA) is a common complication in early pregnancy.
• Progestogens are often used to support pregnancy in cases of TA.

Purpose of the Study:

• To evaluate the effect of progestogen therapy on pregnancy outcomes in women with threatened abortion.
• To compare serum progesterone levels and abortion rates among different treatment groups.

Main Methods:

• A prospective study included 251 pregnant women with threatened abortion (less than 20 weeks gestational age).
• Group 1 received progestogen treatment, Group 2 was monitored without progestogens, and Group 3 served as a healthy control group.
• Pregnancy outcomes and serum progesterone levels were analyzed.

Main Results:

• Serum progesterone levels were significantly higher in the progestogen-treated group (Group 1) compared to the other groups (p < 0.001).
• Abortion rates were statistically similar across all three study groups.
• Despite elevated progesterone, progestogen supplementation did not demonstrate a beneficial effect on pregnancy outcomes in threatened abortion.

Conclusions:

• Progestogen supplementation effectively increases serum progesterone levels in women with threatened abortion.
• Current evidence suggests progestogen therapy does not improve pregnancy outcomes in threatened abortion cases.
• Further research may be needed to identify specific subgroups that could benefit from progestogen support.